Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer.
Christine Pich-BavastroLaura YerlyJeremy Di DomizioStéphanie R TissotMichel GillietFrançois KuonenPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Altogether, our data identify the cellular and molecular plasticity of TME and the pivotal role of Activin A in polarizing the TME towards immune suppression and ICI resistance.